PSTX(Delisted)
Poseida TherapeuticsยทNASDAQ
--
--(--)
PSTX Profile
Poseida Therapeutics, Inc.
A clinical-stage biopharmaceutical company that develops gene therapies for hematological malignancies and solid tumors
9390 Towne Centre Drive, Suite 200, San Diego, CA 92121
--
Poseida Therapeutics, Inc., was incorporated under the laws of the State of Delaware on December 16, 2014. The company is a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases. The company's proprietary genetic engineering technology is used to create product candidates consisting primarily of specific T cell subpopulations, stem cell memory or TSCM, with the goal of compensating for the limitations of CAR-T therapies, including treatment duration, therapeutic capacity for solid tumors and tolerability issues. The company believes that the company's management team's experience in cell and genetic engineering will help rapid development, and hopes to obtain approval to commercialize potential therapeutic cell and gene therapies.
